发明名称 |
New double-stranded interfering RNA, useful for inhibiting hepatitis C virus, has one strand linked to a lipophilic group to improve activity and eliminate the need for transfection auxiliaries |
摘要 |
Double-stranded RNA (I) having a strand (S1) that is complementary, at least in parts, to a target gene (TG) and, the new feature, linked to at least one lipophilic group (A) is new. An Independent claim is also included for a method for producing (I) by solid-phase synthesis, in the 3' to 5' direction, of S1 and/or S2, that uses in the last synthesis cycle a lipophilic molecule that contains a phosphoramidite group.
|
申请公布号 |
DE10302421(A1) |
申请公布日期 |
2004.07.29 |
申请号 |
DE20031002421 |
申请日期 |
2003.01.21 |
申请人 |
RIBOPHARMA AG |
发明人 |
HADWIGER, PHILIPP;JOHN, MATTHIAS;LORENZ, CHRISTINA;VORNLOCHER, HANS-PETER;KREUTZER, ROLAND;LIMMER, STEFAN |
分类号 |
A61K38/00;A61P31/14;C12N15/11;C12N15/113;(IPC1-7):A61K31/713;A61K48/00;A61K31/708;C07H21/02 |
主分类号 |
A61K38/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|